> top > docs > PMC:7029452 > spans > 3240-5201 > annotations

PMC:7029452 / 3240-5201 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
70 598-601 Gene denotes ARS Gene:6012
71 207-214 Species denotes patient Tax:9606
72 374-381 Species denotes patient Tax:9606
73 703-710 Species denotes patient Tax:9606
74 55-63 Disease denotes COVID-19 MESH:C000657245
75 111-119 Disease denotes COVID-19 MESH:C000657245
76 288-307 Disease denotes infectious diseases MESH:D003141
77 645-654 Disease denotes infection MESH:D007239
79 1110-1113 Gene denotes ARS Gene:6012
83 1407-1415 Species denotes patients Tax:9606
84 1421-1453 Disease denotes Middle East respiratory syndrome MESH:D018352
85 1455-1459 Disease denotes MERS MESH:D018352
88 1768-1778 Species denotes SARS-CoV-2 Tax:2697049
89 1950-1960 Species denotes SARS-CoV-2 Tax:2697049

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 1519-1542 Body_part denotes upper respiratory tract http://purl.org/sig/ont/fma/fma45661
T2 1606-1629 Body_part denotes lower respiratory tract http://purl.org/sig/ont/fma/fma45662
T3 1688-1694 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1519-1542 Body_part denotes upper respiratory tract http://purl.obolibrary.org/obo/UBERON_0001557
T2 1525-1542 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T3 1606-1629 Body_part denotes lower respiratory tract http://purl.obolibrary.org/obo/UBERON_0001558
T4 1612-1629 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T5 1688-1694 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T26 55-63 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T27 111-119 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T28 288-298 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T29 598-601 Disease denotes ARS http://purl.obolibrary.org/obo/MONDO_0014648
T30 636-654 Disease denotes hospital infection http://purl.obolibrary.org/obo/MONDO_0043544
T31 645-654 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T32 1110-1113 Disease denotes ARS http://purl.obolibrary.org/obo/MONDO_0014648
T33 1768-1776 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T34 1768-1772 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T35 1950-1958 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T36 1950-1954 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T20 109-110 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 249-250 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T22 276-277 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23 423-424 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 473-476 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T25 512-516 http://purl.obolibrary.org/obo/CLO_0001568 denotes a 24
T26 806-807 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T27 992-993 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T28 1106-1113 http://purl.obolibrary.org/obo/CLO_0001912 denotes the ARS
T29 1606-1629 http://purl.obolibrary.org/obo/UBERON_0001558 denotes lower respiratory tract
T30 1812-1814 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T31 1875-1882 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T32 1921-1925 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 1171-1182 Chemical denotes application http://purl.obolibrary.org/obo/CHEBI_33232

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T27 0-26 Sentence denotes French surveillance system
T28 27-337 Sentence denotes In France, according to the COVID-19 surveillance protocol, physicians suspecting a COVID-19 case have to contact immediately either the emergency hotline (SAMU-Centre 15), if the patient is seeking medical attention from a general practitioner, or a referring infectious diseases specialist at hospital level.
T29 338-451 Sentence denotes Together, they evaluate whether the patient matches the case definition criteria for a possible case (see below).
T30 452-805 Sentence denotes If they do, the case has to be reported immediately through a 24/7 available phone line to the Regional Health Agency (Agence régionale de santé, ARS), which informs without delay the hospital infection control teams involved in the management of the patient, the French Public Health Agency (Santé publique France, SpFrance) and the Ministry of Health.
T31 806-1127 Sentence denotes A standardised investigation form collecting socio-demographical information, clinical details and history of exposure (history of travel to or residence in Wuhan, China or contact with a confirmed case) is completed for each possible case at regional level, in collaboration between the clinicians, the ARS and SpFrance.
T32 1128-1212 Sentence denotes Data are entered into the secure web-based application Voozanoo (Epiconcept, Paris).
T33 1213-1465 Sentence denotes Possible cases have to be hospitalised, isolated and cared for in one of the 38 French referral hospitals designated by the Ministry of Health, according to the guidelines for the management of patients with Middle East respiratory syndrome (MERS) [3].
T34 1466-1805 Sentence denotes For each possible case, respiratory samples from the upper respiratory tract (nasopharyngeal swabs or aspirates) and when possible from the lower respiratory tract (bronchoalveolar lavage fluid, when indicated, or induced sputum) are collected and sent to one of the laboratories accredited to perform SARS-CoV-2-specific real-time RT-PCR.
T35 1806-1961 Sentence denotes Until 27 January, only the National Reference Centre for respiratory viruses (Institut Pasteur, Paris) was able to test for the presence of the SARS-CoV-2.